Phase I trial of FRM-0334 in healthy volunteers

Trial Profile

Phase I trial of FRM-0334 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 10 Feb 2015

At a glance

  • Drugs FRM 0334 (Primary)
  • Indications Alzheimer's disease; Dementia; Neurodegenerative disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Feb 2015 Results were published in a FORUM Pharmaceuticals media release.
    • 15 Dec 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top